Sen. Cornyn Issues Statement on Hahn Nomination to Be FDA Commissioner
November 01, 2019
November 01, 2019
WASHINGTON, Nov. 1 -- Sen. John Cornyn, R-Texas, issued the following statement after President Trump announced that he will nominate Stephen Hahn, chief medical executive at the University of Texas MD Anderson Cancer Center in Houston, to be Commissioner of the Food and Drug Administration:
"Dr. Hahn is a skilled physician and dedicated researcher with a keen understanding of medicine and hospital management.
"He has served patients from all over the world we . . .
"Dr. Hahn is a skilled physician and dedicated researcher with a keen understanding of medicine and hospital management.
"He has served patients from all over the world we . . .